Research Article
Determination of Gypenoside A and Gypenoside XLIX in Rat Plasma by UPLC-MS/MS and Applied to the Pharmacokinetics and Bioavailability
Table 2
Stability of gypenoside A and gypenoside XLIX in rat plasma (%).
| Compound | Concentration (ng/mL) | Autosampler (4°C, 12 h) | Ambient (2 h) | −20°C (30 d) | Freeze-thaw | Accuracy | RSD | Accuracy | RSD | Accuracy | RSD | Accuracy | RSD |
| Gypenoside A | 5 | 101.9 | 7.8 | 93.7 | 9.2 | 102.7 | 13.3 | 110.3 | 14.8 | 250 | 100.5 | 2.8 | 99.9 | 5.3 | 93.8 | 7.2 | 108.6 | 7.2 | 2500 | 96.6 | 5.6 | 106.0 | 5.6 | 99.8 | 5.9 | 92.2 | 6.0 | 5 | 101.1 | 11.7 | 107.7 | 11.5 | 112.2 | 14.5 | 91.2 | 13.3 |
| Gypenoside XLIX | 250 | 108.6 | 8.4 | 97.4 | 6.5 | 90.7 | 7.9 | 87.9 | 13.0 | 2500 | 99.5 | 8.0 | 95.5 | 8.8 | 88.0 | 1.4 | 103.9 | 9.5 |
|
|